Optical coherence tomography (OCT)–guided percutaneous coronary intervention (PCI) in high-risk patients results in larger minimum stent area (MSA) than angiography guidance, but provides no apparent clinical benefit to target-vessel failure (TVF) at 2 years, according to new data from the ILUMIEN IV trial.